A non-core eye care business that was spun off from Novartis.
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Not enough scored insights about Alcon Inc. in the last 30 days yet.
The 1 sources with the most insights about Alcon Inc. on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.
Mentioned as a non-core business spun off by Novartis as part of a strategy that unlocked approximately $180 billion in shareholder value.
Other assets that creators frequently mention in the same content as Alcon Inc..
The most active sources covering Alcon Inc. (ALC) on Kazuha are Andreessen Horowitz. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about Alcon Inc. (ALC) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Alcon Inc. (ALC) most frequently also discuss PLTR, GSK, NVS, SDZ, PFE. See the "Discussed alongside" section above for full asset pages.